James Gordon
Stock Analyst at J.P. Morgan
(3.16)
# 2,517
Out of 5,055 analysts
495
Total ratings
54.8%
Success rate
1.9%
Average return
Main Sectors:
Stocks Rated by James Gordon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: ONT Oxford Nanopore Technologies plc | Reiterated: Buy | 190p → 220p | 209p | +5.47% | 14 | Aug 27, 2026 | |
| BIT: REC Recordati Industria Chimica e Farmaceutica S.p.A. | Reiterated: Buy | €67.00 → €70.00 | €53.00 | +32.08% | 10 | Dec 8, 2025 | |
| LON: GSK GSK plc | Reiterated: Sell | 1,400p | 1,816p | n/a | 164 | Sep 18, 2025 | |
| SWX: SDZ Sandoz Group AG | Reiterated: Buy | CHF 46.00 → CHF 55.00 | CHF 73.82 | n/a | 3 | Sep 16, 2025 | |
| LON: HIK Hikma Pharmaceuticals PLC | Reiterated: Buy | 2,500p | 1,602p | n/a | 27 | Aug 8, 2025 | |
| ARGX argenx SE | Reiterated: Buy | $775 → $830 | $818.30 | n/a | 16 | Aug 4, 2025 | |
| LON: AZN AstraZeneca PLC | Reiterated: Buy | 14,000p | 12,300p | n/a | 169 | Jul 29, 2025 | |
| SWX: GALD Galderma Group AG | Reiterated: Buy | CHF 120.00 → CHF 160.00 | CHF 171.85 | n/a | 2 | Jul 25, 2025 | |
| LON: OXB Oxford Biomedica plc | Reiterated: Hold | 490p → 400p | 512p | n/a | 7 | Jul 15, 2025 | |
| BME: GRF Grifols, S.A. | Reiterated: Hold | €9.50 → €12.00 | €9.81 | n/a | 14 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11 → $10 | $7.24 | n/a | 14 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 1.20 → CHF 1.00 | CHF 4.24 | n/a | 14 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €34.00 → €29.00 | €26.04 | n/a | 8 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $37 → $32 | $29.40 | n/a | 8 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 → $15 | $19.01 | n/a | 11 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $44 | $88.21 | n/a | 3 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 55.00 → CHF 57.00 | CHF 53.38 | n/a | 5 | Nov 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 400.00 | CHF 370.90 | n/a | 1 | May 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $42.03 | n/a | 1 | Apr 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | 8,141p → 9,251p | 68p | n/a | 2 | Dec 29, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $47.87 | n/a | 2 | Aug 15, 2016 |
Oxford Nanopore Technologies plc
Aug 27, 2026
Reiterated: Buy
Price Target: 190p → 220p
Current: 209p
Upside: +5.47%
Recordati Industria Chimica e Farmaceutica S.p.A.
Dec 8, 2025
Reiterated: Buy
Price Target: €67.00 → €70.00
Current: €53.00
Upside: +32.08%
GSK plc
Sep 18, 2025
Reiterated: Sell
Price Target: 1,400p
Current: 1,816p
Upside: n/a
Sandoz Group AG
Sep 16, 2025
Reiterated: Buy
Price Target: CHF 46.00 → CHF 55.00
Current: CHF 73.82
Upside: n/a
Hikma Pharmaceuticals PLC
Aug 8, 2025
Reiterated: Buy
Price Target: 2,500p
Current: 1,602p
Upside: n/a
argenx SE
Aug 4, 2025
Reiterated: Buy
Price Target: $775 → $830
Current: $818.30
Upside: n/a
AstraZeneca PLC
Jul 29, 2025
Reiterated: Buy
Price Target: 14,000p
Current: 12,300p
Upside: n/a
Galderma Group AG
Jul 25, 2025
Reiterated: Buy
Price Target: CHF 120.00 → CHF 160.00
Current: CHF 171.85
Upside: n/a
Oxford Biomedica plc
Jul 15, 2025
Reiterated: Hold
Price Target: 490p → 400p
Current: 512p
Upside: n/a
Grifols, S.A.
Jun 17, 2025
Reiterated: Hold
Price Target: €9.50 → €12.00
Current: €9.81
Upside: n/a
Jun 17, 2025
Reiterated: Hold
Price Target: $11 → $10
Current: $7.24
Upside: n/a
Dec 3, 2024
Reiterated: Hold
Price Target: CHF 1.20 → CHF 1.00
Current: CHF 4.24
Upside: n/a
Oct 23, 2024
Reiterated: Hold
Price Target: €34.00 → €29.00
Current: €26.04
Upside: n/a
Oct 22, 2024
Reiterated: Hold
Price Target: $37 → $32
Current: $29.40
Upside: n/a
Oct 9, 2024
Reiterated: Hold
Price Target: $13 → $15
Current: $19.01
Upside: n/a
May 8, 2024
Reiterated: Buy
Price Target: $40 → $44
Current: $88.21
Upside: n/a
Nov 16, 2020
Reiterated: Hold
Price Target: CHF 55.00 → CHF 57.00
Current: CHF 53.38
Upside: n/a
May 14, 2020
Reiterated: Buy
Price Target: CHF 400.00
Current: CHF 370.90
Upside: n/a
Apr 2, 2020
Upgraded: Buy
Price Target: n/a
Current: $42.03
Upside: n/a
Dec 29, 2017
Reiterated: Hold
Price Target: 8,141p → 9,251p
Current: 68p
Upside: n/a
Aug 15, 2016
Reiterated: Hold
Price Target: n/a
Current: $47.87
Upside: n/a